PWA
APGE icon

Physician Wealth Advisors’s Apogee Therapeutics APGE Stock Holding History

Physician Wealth Advisors’s Portfolio APGE Stock Details APGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$797 Buy
+6
New +$541 ﹤0.01% 1915
2025
Q3 		– Sell
-18
Closed -$782 – 1910
2025
Q2 		$782 Buy
+18
New +$685 ﹤0.01% 1563

Other funds holding APGE

Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
TH
Transmarket Holdings Chicago, Illinois $136M AUM
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $516M AUM 28.38% 1-Year Est. Return

Physician Wealth Advisors's APGE Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Apogee Therapeutics (APGE) in Q2 2026: 6 shares worth $797. The stake represents ﹤0.01% of the portfolio and ranks #1915 among its holdings. This is a return to the name: Physician Wealth Advisors previously reported a position in APGE as recently as Q2 2025.

Physician Wealth Advisors first reported a position in APGE in Q2 2025 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold APGE as of Q2 2026.

  • Physician Wealth Advisors held 6 shares of Apogee Therapeutics worth $797 as of Q2 2026.
  • Apogee Therapeutics was a new Physician Wealth Advisors position in Q2 2026.
  • Apogee Therapeutics made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #1915 holding.
  • Physician Wealth Advisors first reported a position in Apogee Therapeutics in Q2 2025 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Apogee Therapeutics as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.